Andrew C Furman, MD - Medicare Psychiatry in Atlanta, GA

Andrew C Furman, MD is a medicare enrolled "Psychiatry & Neurology - Psychiatry" physician in Atlanta, Georgia. He went to Emory University School Of Medicine and graduated in 1991 and has 33 years of diverse experience with area of expertise as Psychiatry. He is a member of the group practice The Emory Clinic, Inc and his current practice location is 2004 Ridgewood Dr Ne, Atlanta, Georgia. You can reach out to his office (for appointments etc.) via phone at (404) 727-5886.

Andrew C Furman is licensed to practice in Georgia (license number 036158) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1205902277.

Contact Information

Andrew C Furman, MD
2004 Ridgewood Dr Ne,
Atlanta, GA 30322-1031
(404) 727-5886
Not Available



Physician's Profile

Full NameAndrew C Furman
GenderMale
SpecialityPsychiatry
Experience33 Years
Location2004 Ridgewood Dr Ne, Atlanta, Georgia
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Andrew C Furman attended and graduated from Emory University School Of Medicine in 1991
  NPI Data:
  • NPI Number: 1205902277
  • Provider Enumeration Date: 11/28/2006
  • Last Update Date: 07/08/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 2466646518
  • Enrollment ID: I20101102001020

Medical Identifiers

Medical identifiers for Andrew C Furman such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1205902277NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0800XPsychiatry & Neurology - Psychiatry 036158 (Georgia)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
The Emory Clinic, Inc88209014082687

News Archive

Expensive 'high tech' therapy not superior to home training for walking recovery of stroke survivors

Home-based physical therapy to improve the strength and balance of stroke survivors works about as well to get them walking again as treadmill training done in a physical therapy lab, according to the results of a study presented today by a Duke researcher at the American Stroke Association's International Stroke Conference.

EC approves Sosei's Seebri Breezhaler to treat COPD

Sosei Group Corporation confirms the information released today by Novartis that the European Commission has approved Seebri Breezhaler (glycopyrronium bromide) 44 mcg delivered dose (equivalent to 50 mcg glycopyrronium measured dose per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

ChromaDex reports 31% revenue growth in first quarter 2013

ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, announced today financial results for the first quarter ended March 30, 2013.

Researchers find protein that controls neurotransmission: findings may lead to new drugs to treat neurological disorders

Scientists at Weill Cornell Medical College have discovered that the single protein - alpha 2 delta - exerts a spigot-like function, controlling the volume of neurotransmitters and other chemicals that flow between the synapses of brain neurons. The study, published online in Nature, shows how brain cells talk to each other through these signals, relaying thoughts, feelings and action, and this powerful molecule plays a crucial role in regulating effective communication.

Scientists discover mechanism by which TNFα stimulates tumor formation

An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Andrew C Furman allows following entities to bill medicare on his behalf.
Entity NameThe Emory Clinic Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1396798229
PECOS PAC ID: 8820901408
Enrollment ID: O20031110000503

News Archive

Expensive 'high tech' therapy not superior to home training for walking recovery of stroke survivors

Home-based physical therapy to improve the strength and balance of stroke survivors works about as well to get them walking again as treadmill training done in a physical therapy lab, according to the results of a study presented today by a Duke researcher at the American Stroke Association's International Stroke Conference.

EC approves Sosei's Seebri Breezhaler to treat COPD

Sosei Group Corporation confirms the information released today by Novartis that the European Commission has approved Seebri Breezhaler (glycopyrronium bromide) 44 mcg delivered dose (equivalent to 50 mcg glycopyrronium measured dose per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

ChromaDex reports 31% revenue growth in first quarter 2013

ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, announced today financial results for the first quarter ended March 30, 2013.

Researchers find protein that controls neurotransmission: findings may lead to new drugs to treat neurological disorders

Scientists at Weill Cornell Medical College have discovered that the single protein - alpha 2 delta - exerts a spigot-like function, controlling the volume of neurotransmitters and other chemicals that flow between the synapses of brain neurons. The study, published online in Nature, shows how brain cells talk to each other through these signals, relaying thoughts, feelings and action, and this powerful molecule plays a crucial role in regulating effective communication.

Scientists discover mechanism by which TNFα stimulates tumor formation

An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.

Read more Medical News

› Verified 8 days ago

Entity NameEmory Medical Care Foundation Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063452381
PECOS PAC ID: 4981501814
Enrollment ID: O20031217000968

News Archive

Expensive 'high tech' therapy not superior to home training for walking recovery of stroke survivors

Home-based physical therapy to improve the strength and balance of stroke survivors works about as well to get them walking again as treadmill training done in a physical therapy lab, according to the results of a study presented today by a Duke researcher at the American Stroke Association's International Stroke Conference.

EC approves Sosei's Seebri Breezhaler to treat COPD

Sosei Group Corporation confirms the information released today by Novartis that the European Commission has approved Seebri Breezhaler (glycopyrronium bromide) 44 mcg delivered dose (equivalent to 50 mcg glycopyrronium measured dose per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

ChromaDex reports 31% revenue growth in first quarter 2013

ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, announced today financial results for the first quarter ended March 30, 2013.

Researchers find protein that controls neurotransmission: findings may lead to new drugs to treat neurological disorders

Scientists at Weill Cornell Medical College have discovered that the single protein - alpha 2 delta - exerts a spigot-like function, controlling the volume of neurotransmitters and other chemicals that flow between the synapses of brain neurons. The study, published online in Nature, shows how brain cells talk to each other through these signals, relaying thoughts, feelings and action, and this powerful molecule plays a crucial role in regulating effective communication.

Scientists discover mechanism by which TNFα stimulates tumor formation

An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Andrew C Furman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Andrew C Furman, MD
2004 Ridgewood Dr Ne,
Atlanta, GA 30322-1031

Ph: (404) 727-5886
Andrew C Furman, MD
2004 Ridgewood Dr Ne,
Atlanta, GA 30322-1031

Ph: (404) 727-5886

News Archive

Expensive 'high tech' therapy not superior to home training for walking recovery of stroke survivors

Home-based physical therapy to improve the strength and balance of stroke survivors works about as well to get them walking again as treadmill training done in a physical therapy lab, according to the results of a study presented today by a Duke researcher at the American Stroke Association's International Stroke Conference.

EC approves Sosei's Seebri Breezhaler to treat COPD

Sosei Group Corporation confirms the information released today by Novartis that the European Commission has approved Seebri Breezhaler (glycopyrronium bromide) 44 mcg delivered dose (equivalent to 50 mcg glycopyrronium measured dose per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

ChromaDex reports 31% revenue growth in first quarter 2013

ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, announced today financial results for the first quarter ended March 30, 2013.

Researchers find protein that controls neurotransmission: findings may lead to new drugs to treat neurological disorders

Scientists at Weill Cornell Medical College have discovered that the single protein - alpha 2 delta - exerts a spigot-like function, controlling the volume of neurotransmitters and other chemicals that flow between the synapses of brain neurons. The study, published online in Nature, shows how brain cells talk to each other through these signals, relaying thoughts, feelings and action, and this powerful molecule plays a crucial role in regulating effective communication.

Scientists discover mechanism by which TNFα stimulates tumor formation

An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.

Read more News

› Verified 8 days ago


Psychiatry & Neurology Doctors in Atlanta, GA

Dr. Marc A. Safran, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 1600 Clifton Rd Ne, To: Capt Marc Safran, Us Public Health Service, Cdc, Atlanta, GA 30329
Phone: 404-639-3311    
Dr. Allison Nitsche, M.D.
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 7000 Peachtree Dunwoody Rd Ste 100, Atlanta, GA 30328
Phone: 770-393-1880    
Dr. Shamina Jaffer Henkel, M.D.
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: Childrens Healthcare Of Atlanta, 1405 Clifton Road, Ne, Atlanta, GA 30322
Phone: 404-785-6244    Fax: 404-785-6268
Deborah Ida Botti, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 3400 Peachtree Rd, Suite 915, Atlanta, GA 30326
Phone: 404-812-0011    
Dr. Jeffrey Lee Winston, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 4546 Barclay Dr Ste B, Atlanta, GA 30338
Phone: 770-457-7994    Fax: 770-458-8656
Dr. Alan Marc Weinberg, M.D.
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 20 Glenlake Pkwy, Dept Of Behavioral Health, Atlanta, GA 30328
Phone: 404-365-0966    Fax: 770-389-3030
Dr. Norman Abrams, MD
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 1269 Heards Ferry Rd Nw, Atlanta, GA 30328
Phone: 770-951-2248    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.